Please login to the form below
Vir Biotech plans to start mid-to-late stage study of COVID-19 antibody this month
Monoclonal antibody has neutralised SARS-CoV-2 virus in vitro
Seres’ microbiome-based therapy hits the mark in phase 3
Drug reduced C.difficile infection recurrence
Eli Lilly, Innovent showcase Tyvyt data in first-line NSCLC
Detailed phase 3 results presented at the virtual World Conference on Lung Cancer
Biogen’s highly-anticipated Alzheimer’s drug wins FDA fast-track
Drug could become first treatment to reduce clinical decline in Alzheimer's
Bristol-Myers Squibb’s revenues rise on Celgene acquisition
Sales of immunotherapy Opdivo decreased due to COVID-19 impact
Tecentriq combo fails in advanced triple negative breast cancer
Tecentriq plus paclitaxel failed to improve progression-free survival
Biogen pays Denali $1bn upfront for Parkinson’s disease programme
Deal includes portfolio of small molecule LRRK2 inhibitors
Novartis builds its case for novel MS treatment ofatumumab
Detailed results from phase 3 studies published in NEJM
Pfizer’s Xalkori follow-up Lorbrena hits the mark in first-line lung cancer
ALK inhibitor improved progression-free survival in first-line setting
Adopting a creative IP approach towards biotech clusters
Why big pharma paradigm needs to change
-
A unique ecosystem How life science and healthcare clusters are driving innovation
-
Riding the wave of digital disruptionThe challenges and rewards of meeting consumer expectations
-
AbbVie exits Voyager alliance for Alzheimer’s/Parkinson’s gene therapiesBiotech company did not disclose the reason for the partnership's end
-
Merck enters agreement with Hanmi for investigational NASH drugLicensing agreement includes $10m upfront payment
-
Novavax reports promising phase 1 results for coronavirus vaccine Candidate induced immune response in early-stage clinical trial
-
AbbVie, Amgen and Takeda team up for joint COVID-19 trialCollaborative trial will evaluate three anti-inflammatory drugs
-
Eli Lilly begins COVID-19 prevention trial in nursing homesTrial will investigate monoclonal antibody in up to 2,400 participants
-
NeuroRx, Relief Therapeutics’ COVID-19 drug demonstrates early potentialDrug produced rapid recovery in critically-ill patients
-
US secures 100 million doses of Sanofi/GSK’s COVID-19 vaccine
Both companies are also in talks with EU for access to candidate
-
Azafaros expands executive team with three senior hiresKyle Landskroner, Ruben Giorgino and Louise Kooij join the team
-
Ex-BMS exec jumps to Gilead to lead research group Gilead appoints Michael Quigley to lead research team
-
New hires at Crescendo, Healx and Galecto The latest movers in pharma
-
Ex-Roche CMO Sandra Horning joins Gilead’s board of directorsHorning retired from Roche last August
-
F-star hires ex-BMS immuno-oncology leader
New CMO to oversee development of lead candidate
Latest research appointments
COVID-19 Updates and Daily News
Featured jobs
- Roche scores FDA approval for SMA drug risdiplam, now named Evrysdi
- New study identifies drugs that are safe to use in COVID-19 treatment
- How will the events and exhibitions industry change post-Coronavirus?
- Biogen pays Denali $1bn upfront for Parkinson’s disease programme
- Tecentriq combo fails in advanced triple negative breast cancer
- Merck enters agreement with Hanmi for investigational NASH drug
- Virtual Hackathon on Healthcare Innovation: a Customer Story
- OPEN Health at the World Orphan Drug Conference USA
- US pays $1.5bn for 100 million doses of Moderna’s COVID-19 vaccine
- Vir Biotech plans to start mid-to-late stage study of COVID-19 antibody this month
- Russia becomes first country to approve a COVID-19 vaccine
- Can involving patients in design transform the clinical trial experience?
PMHub
Creative Medical Research
Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...
Latest intelligence
- Virtual Hackathon on Healthcare Innovation: a Customer Story
- How participants from 9 different countries in the APAC region were brought together to participate in a pharmaceutical company-wide 3-day virtual "hackathon," with spectacular results....
- OPEN Health at the World Orphan Drug Conference USA
- Our Director of Rare Disease, Gavin Jones looks forward to his conversation with Emily Crossle & Betsy Bogard at #WODCUSA2020 !...
- Can involving patients in design transform the clinical trial experience?
- While the research space is a heavily regulated environment and there are rules that we must abide by, this doesn’t mean clinical study materials have to be ‘boring’ or the...
Quick links
Infographics
